Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First patient dosed in phase Ib/II study of dubermatinib plus decitabine in AML

Oct. 26, 2020

New phase II trial investigates PT-112 for metastatic CRPC

Oct. 23, 2020

SGX-301 continues to demonstrate positive benefits in phase III FLASH study

Oct. 23, 2020

Galera initiates phase I/II GRECO-1 study of GC-4711 plus SBRT in NSCLC

Oct. 23, 2020

Tera Stone synthesizes new compounds for cancer

Oct. 23, 2020

TaiwanJ Pharmaceuticals presents new ENPP2 and HDAC dual inhibitors

Oct. 23, 2020

Kowa discloses CSF-1R inhibitors

Oct. 23, 2020

New CDK inhibitors presented by Aurigene Discovery Technologies

Oct. 22, 2020

First patient enrolled in MERKLIN 2 trial of domatinostat plus avelumab in MCC

Oct. 22, 2020

Array BioPharma presents new PTPN11 inhibitors

Oct. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...